These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 7872624)
1. [Urinary excretion of acetylated polyamines after heart transplantation in dogs]. Thai P; Carrier M; Pelletier LC Ann Chir; 1994; 48(8):742-8. PubMed ID: 7872624 [TBL] [Abstract][Full Text] [Related]
2. Urinary polyamines are noninvasive markers of heart allograft rejection. Carrier M; Copeland JG; Russell DH; Perrotta NJ; Davis TP; Emery RW J Heart Transplant; 1987; 6(5):286-9. PubMed ID: 3316553 [TBL] [Abstract][Full Text] [Related]
3. Urinary excretion of N1-acetylspermidine and other acetylated and free polyamines in the 1,2-dimethylhydrazine model of experimental rat colon cancer. Halline AG; Dudeja PK; Lashner BA; Brasitus TA Cancer Res; 1989 Sep; 49(17):4721-3. PubMed ID: 2758407 [TBL] [Abstract][Full Text] [Related]
4. Value of urinary polyamines as noninvasive markers of cardiac allograft rejection in the dog. Carrier M; Russell DH; Davis TP; Emery RW; Copeland JG Ann Thorac Surg; 1988 Feb; 45(2):158-63. PubMed ID: 3277553 [TBL] [Abstract][Full Text] [Related]
7. Comparison of Neoral and Sandimmune cyclosporine for induction of immunosuppression after heart transplantation. Carrier M; White M; Pellerin M; Pelletier GB; Pelletier LC Can J Cardiol; 1997 May; 13(5):469-73. PubMed ID: 9179085 [TBL] [Abstract][Full Text] [Related]
8. Circadian rhythmicity of polyamine urinary excretion. Hrushesky WJ; Merdink J; Abdel-Monem MM Cancer Res; 1983 Aug; 43(8):3944-7. PubMed ID: 6861156 [TBL] [Abstract][Full Text] [Related]
9. [Effects of acute rejection on the endothelium-dependent relaxation of coronary arteries of the transplanted heart in dogs]. Bouchard D; Cartier R; Despatis MA; Carrier M; Leung TK Ann Chir; 1995; 49(8):735-42. PubMed ID: 8561429 [TBL] [Abstract][Full Text] [Related]
10. Enhanced urinary excretion of N1-acetylspermidine and the presence of tumors. Seiler N; Graham A; Bartholeyns J Cancer Res; 1981 Apr; 41(4):1572-3. PubMed ID: 6897929 [TBL] [Abstract][Full Text] [Related]
11. Urinary polyamine levels are markers of altered T lymphocyte proliferation/loss and rejection in heart transplant patients. Womble JR; Larson DF; Copeland JG; Russell DH Transplant Proc; 1984 Dec; 16(6):1573-5. PubMed ID: 6390864 [TBL] [Abstract][Full Text] [Related]
12. Effects of immunosuppression induced by thalidomide and cyclosporine in heterotopic heart transplantation in rabbits. Carvalho JB; Petroianu A; Travolo E; de Oliveira BH; Duarte AB; Alberti LR Transplant Proc; 2007 Jun; 39(5):1640-1. PubMed ID: 17580207 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of thalidomide as immunosuppressor in heterotopic heart transplantation. de Carvalho JB; Petroianu A; Alberti LR Chirurgia (Bucur); 2008; 103(4):429-34. PubMed ID: 18780616 [TBL] [Abstract][Full Text] [Related]
14. Vascular effects of cyclosporin A and acute rejection in canine heart transplantation. Bouchard D; Despatis MA; Buluran J; Cartier R Ann Thorac Surg; 1997 Nov; 64(5):1325-30. PubMed ID: 9386698 [TBL] [Abstract][Full Text] [Related]
16. Left ventricular dysfunction after heart transplantation: incidence and role of enhanced immunosuppression. McNamara D; Di Salvo T; Mathier M; Keck S; Semigran M; Dec GW J Heart Lung Transplant; 1996 May; 15(5):506-15. PubMed ID: 8771506 [TBL] [Abstract][Full Text] [Related]
17. Renoprotective immunosuppression by pioglitazone with low-dose cyclosporine in rat heart transplantation. Tanaka Y; Hasegawa T; Chen Z; Okita Y; Okada K J Thorac Cardiovasc Surg; 2009 Sep; 138(3):744-51. PubMed ID: 19698865 [TBL] [Abstract][Full Text] [Related]
18. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study. Ross HJ; Gullestad L; Pak J; Slauson S; Valantine HA; Hunt SA J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929 [TBL] [Abstract][Full Text] [Related]
19. Effect of pentoxifylline on renal toxicity of cyclosporine: results of a clinical trial after heart transplantation. Carrier M; Pelletier GB; White M; Bois D; Pelletier LC J Heart Lung Transplant; 1996 Dec; 15(12):1179-83. PubMed ID: 8981202 [TBL] [Abstract][Full Text] [Related]
20. Cyclosporine dosage can be reduced when used in combination with an anti-intercellular adhesion molecule-1 monoclonal antibody in rats undergoing heterotopic heart transplantation. Harrison PC; Mainolfi E; Madwed JB J Heart Lung Transplant; 1998 Feb; 17(2):150-7. PubMed ID: 9513853 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]